Meral Akdoğan

2.5k total citations
105 papers, 1.6k citations indexed

About

Meral Akdoğan is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Meral Akdoğan has authored 105 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hepatology, 47 papers in Epidemiology and 42 papers in Surgery. Recurrent topics in Meral Akdoğan's work include Liver Disease Diagnosis and Treatment (34 papers), Hepatitis B Virus Studies (24 papers) and Hepatitis C virus research (23 papers). Meral Akdoğan is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Hepatitis B Virus Studies (24 papers) and Hepatitis C virus research (23 papers). Meral Akdoğan collaborates with scholars based in Türkiye, United States and Netherlands. Meral Akdoğan's co-authors include Fehmı Tabak, Krzysztof Simon, İbrahim C. Haznedaroğlu, Bettina E. Hansen, Harry L.A. Janssen, Burhan Şahın, Elke Verhey, İbrahi̇m Koral Önal, Mevlüt Kurt and Nurgül Şaşmaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Meral Akdoğan

93 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meral Akdoğan Türkiye 20 887 837 496 226 207 105 1.6k
Sven Wallerstedt Sweden 18 1.1k 1.2× 915 1.1× 535 1.1× 124 0.5× 255 1.2× 41 1.6k
Tuğrul Pürnak Türkiye 20 555 0.6× 629 0.8× 374 0.8× 92 0.4× 65 0.3× 69 1.2k
A. Iacobellis Italy 17 785 0.9× 751 0.9× 288 0.6× 73 0.3× 148 0.7× 44 1.1k
Maximilian Schöniger–Hekele Austria 19 831 0.9× 542 0.6× 414 0.8× 143 0.6× 261 1.3× 35 1.5k
A K Burroughs United Kingdom 24 905 1.0× 787 0.9× 479 1.0× 98 0.4× 82 0.4× 43 1.3k
Etsuko Hashimoto Japan 21 1.8k 2.0× 1.6k 1.9× 422 0.9× 194 0.9× 130 0.6× 55 2.3k
Fabrizio Panaro France 26 893 1.0× 463 0.6× 1.3k 2.6× 77 0.3× 395 1.9× 159 2.0k
Emanuela Testa Italy 15 1.2k 1.3× 1.2k 1.4× 498 1.0× 65 0.3× 50 0.2× 24 1.5k
Dominik Bettinger Germany 22 1.1k 1.2× 736 0.9× 486 1.0× 27 0.1× 262 1.3× 93 1.6k
Ingalill Friis–Liby Sweden 10 397 0.4× 1.1k 1.3× 448 0.9× 41 0.2× 97 0.5× 12 1.4k

Countries citing papers authored by Meral Akdoğan

Since Specialization
Citations

This map shows the geographic impact of Meral Akdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meral Akdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meral Akdoğan more than expected).

Fields of papers citing papers by Meral Akdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meral Akdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meral Akdoğan. The network helps show where Meral Akdoğan may publish in the future.

Co-authorship network of co-authors of Meral Akdoğan

This figure shows the co-authorship network connecting the top 25 collaborators of Meral Akdoğan. A scholar is included among the top collaborators of Meral Akdoğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meral Akdoğan. Meral Akdoğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakut, Mustafa, et al.. (2024). Challenging Conventional Wisdom: Early Treatment and Chronicity Outcomes in Acute Severe Hepatitis B. International Journal of Medical Sciences. 21(15). 2974–2980.
2.
Öztürk, Ömer, et al.. (2024). Manyetik Rezonans Kolanjiopankreatografi ile Nedeni Açıklanamayan Ana Safra Kanalı Dilatasyonunun Retrospektif Analizi. Turkish Journal of Clinics and Laboratory. 15(1). 56–62.
3.
Eser, Fatma, et al.. (2023). Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey. The Journal of Infection in Developing Countries. 17(4). 461–467.
4.
Akdoğan, Meral, et al.. (2022). COVID-19 infection frequency and clinical course in patients with liver transplantation: Results of a single transplant center in Türkiye. Turkish Journal of Surgery. 38(3). 283–288. 1 indexed citations
5.
6.
Öztürk, Ömer, et al.. (2022). SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT. Gastroenterology Nursing. 45(6). 449–451. 1 indexed citations
7.
Kaplan, Mustafa, et al.. (2021). The prognostic utility of ascites sodium level in cirrhotic patients. DergiPark (Istanbul University). 20(2). 87–93.
8.
Akarca, Ulus Salih, Belkıs Ünsal, Orhan Sezgın, et al.. (2021). Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. The Turkish Journal of Gastroenterology. 32(12). 1019–1028. 2 indexed citations
9.
Akarsu, Mesut, İlker Turan, Gupse Adalı, et al.. (2021). Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. The Turkish Journal of Gastroenterology. 32(9). 712–719. 6 indexed citations
10.
Kaçar, Sabite, et al.. (2020). Bezoar in upper gastrointestinal endoscopy: A single center experience. The Turkish Journal of Gastroenterology. 31(2). 85–90. 16 indexed citations
11.
Kaçar, Sabite, et al.. (2019). Toxic hepatitis and hyponatremia: Case report. The Turkish Journal of Gastroenterology. 30(Supp1). 51–52.
12.
Campenhout, Margo J. H. van, Willem Pieter Brouwer, Qing Xie, et al.. (2018). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis. 26(1). 109–117. 14 indexed citations
13.
Özdemir, Mustafa, et al.. (2017). Multidetector Computed Tomography Findings of Splenic Artery Aneurysms Associated With Liver Involvement in Wilson's Disease. Transplantation Proceedings. 49(8). 1806–1809. 3 indexed citations
14.
Kuzu, Ufuk Barış, Erkin Öztaş, Fatih Saygılı, et al.. (2016). The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C. The Turkish Journal of Gastroenterology. 27(2). 156–164. 14 indexed citations
15.
Kuzu, Ufuk Barış, Mustafa Özdemir, Hakan Yıldız, et al.. (2015). Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors. Transplantation Proceedings. 47(6). 1854–1859. 2 indexed citations
16.
Oruç, Nevin, et al.. (2010). 182 THERAPEUTIC EFFICACY OF L-ORNITHINE-L-ASPARTATE INFUSIONS IN PATIENTS WITH CIRRHOSIS AND HEPATIC ENCEPHALOPATHY. Journal of Hepatology. 52. S78–S79. 3 indexed citations
17.
Kekilli, Murat, Abdurrahim Sayılır, Yusuf Yeşil, et al.. (2009). Servikal özofagustaki heterotopik gastrik mukozanın endoskopik sıklığı; bir referans merkez çalışması. 8(3). 119–122.
18.
Arhan, Mehmet, et al.. (2007). Karaciğer Fibrozisinin Değerlendirilmesinde Serum Hyaluronik Asit Düzeyinin Yeri. Turkiye Klinikleri Tip Bilimleri Dergisi. 27(1). 21–26. 1 indexed citations
19.
Canbakan, Billur, Hakan Şentürk, Fehmı Tabak, et al.. (2006). Efficacy of interferon α‐2b and lamivudine combination treatment in comparison to interferon α‐2b alone in chronic delta hepatitis: A randomized trial. Journal of Gastroenterology and Hepatology. 21(4). 657–663. 29 indexed citations
20.
Akdoğan, Meral, et al.. (2003). Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?. PubMed. 14(3). 181–4. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Wallerstedt Breakdown of academic impact, for papers by Tuğrul Pürnak Breakdown of academic impact, for papers by A. Iacobellis Breakdown of academic impact, for papers by Maximilian Schöniger–Hekele Breakdown of academic impact, for papers by A K Burroughs Breakdown of academic impact, for papers by Etsuko Hashimoto Breakdown of academic impact, for papers by Fabrizio Panaro Breakdown of academic impact, for papers by Emanuela Testa Breakdown of academic impact, for papers by Dominik Bettinger Breakdown of academic impact, for papers by Ingalill Friis–Liby
Rankless by CCL
2026